September 11, 2024 Top Stocks For Smart Investment Choices
September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
August 26, 2024 NVDA Earnings Report Insights
Amazon: Oracle Partnership Highlights Margin Expansion Potential
Nvidia: Why You Should Buy Before It Hits $145
Apple: Enough To Turn The Odds In Its Favor – Still Buy
AMD Is Coming For Nvidia’s AI Lead
Nvidia: Goldman Sachs’ Hilarious Downside Case
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
UnitedHealth (UNH) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: September 13, 2024 (13:04)
Sector: HealthcareThe share price of UnitedHealth Group, Inc. (UNH) now
News Impact Analyzer
Full report|
This Week
|
Bullish | Impact: 1.13 | News: 2 (1/0/1) |
|
Previous Week
|
Bullish | Impact: 1.13 | News: 3 (1/1/1) |
|
Two Weeks Ago
|
Bullish | Impact: 5 | News: 4 (3/1/0) |
|
Three Weeks Ago
|
Na | Impact: Na | News: Na |
Analysts predictions
Full report|
This Week
|
Bullish | Opinions: 4 (2/1/1) |
|
Previous Week
|
Neutral | Opinions: Na |
|
Two Weeks Ago
|
Neutral | Opinions: Na |
|
Three Weeks Ago
|
Neutral | Opinions: Na |
Analyzing the Most Important UNH news
UnitedHealth Drops Humira: Focus Shifts to Biosimilars
CVS and Humana Slide as New Mental Health Rules Loom Over Insurers
UnitedHealth Group Takes a Breather After Six-Day Streak
Historical and forecast chart of UnitedHealth stock
The chart below shows the historical price of UnitedHealth stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the UnitedHealth stock price can be found in the table below.
Long-term forecasts by years.
UnitedHealth Group, Inc. Analysts predictions review
As of now, Panda has combed through 4 analytical articles which are directly related to UNH from the last 30 days. Out of these, 2 clearly showcase a bullish trend, while 1 see a bearish trend as the more likely scenario, and 1 stay neutral.
To identify the dominant trend, we took into account analytical articles from the past 30 days, spanning from Sep 12, 2024 to Sep 13, 2024.
UnitedHealth Faces Market Valuation Challenges: Navigating Diminished Growth and Overvaluation Risks
In his latest analytical piece on UnitedHealth Group (UNH) stock, Leon Laake offers a comprehensive examination while maintaining a Neutral stance. Despite being relatively new to contribution, with 31 publications since 2022, Laake has rapidly gained traction, drawing 677 subscribers to his insights. His viewpoints, while still maturing in credibility, have garnered respect and attention within the financial analysis community. By producing a significant number of articles in a short span, Laake demonstrates both commitment and expertise in his field. Although his authority is still developing, this article reflects a balanced perspective on UNH stock, making it valuable for readers seeking an objective overview. Laake’s analysis will likely continue to mature and build influence as he maintains his growing presence in financial commentary.
Key Theses
- UnitedHealth Group (UNH) has solid business fundamentals but is currently trading at an unhealthy valuation, limiting potential upside.
- The company's growth prospects are relatively lower compared to historical averages, impacting future stock price increases.
- The current stock valuation is above the historical mean, presenting downside risks if growth expectations are not met.
- Potential returns from UNH are uninspired compared to the risks, suggesting alternative investments might offer better outcomes.
Factors Influencing UNH Stock Price
Current Valuation vs. Historical Mean
UNH is trading significantly above its historical mean valuation, indicating potential downside risk as stocks revert to the mean. This overvaluation restricts upside potential and positions UNH at risk if market or company expectations change.
Growth Prospects
Despite solid company fundamentals, UNH's growth projections range between 10-13%, which are uninspired compared to past performance. The lower growth forecasts don't justify the current high valuation, putting pressure on stock performance.
Free Cash Flow
UNH's free cash flow is significantly below the mean, indicating operational health concerns and limiting valuation expansion. The lower cash flow might necessitate adjustments in analyst forecasts, negatively impacting stock price.
Analysts' EPS Predictions
Analysts have reduced their EPS expectations for UNH except for one forward year, signaling a bearish outlook that could influence stock price performance. However, an overall market overvaluation tempers its immediate impact.
Review the original Analysis
UnitedHealth: A Robust Path to Growth Amidst Challenges and Expansion
Hunter Wolf Research has delivered yet another insightful analysis, this time maintaining a Strong Bullish stance on UNH stock. The author is a seasoned contributor, with 116 publications since 2015, indicating a dedicated and prolific presence in the financial analysis space. His viewpoints have earned the trust of 1,636 subscribers, underscoring his popularity among readers. With a high credibility level, his expertise is further solidified by the impressive authority of his analyses. Readers can rely on his assessments to be both well-researched and reliable. This review promises to be a valuable resource for investors looking to make informed decisions about UNH stock, firmly grounded in the expertise and reputation of Hunter Wolf Research.
Key Theses of the Review
- UnitedHealth's aggressive M&A strategy, including the acquisition of Change Healthcare, strengthens its data analytics capabilities and improves margins.
- The recent cyberattack has had a manageable financial impact, with expected EPS reduction and increased CAPEX for cybersecurity enhancements.
- Divesting the Brazilian business reduces foreign exchange risk and aligns with a focus on U.S. market growth driven by healthcare spending.
- An estimated 8% revenue growth from market expansion and acquisitions leads to a one-year target price of $700 per share.
Factors Influencing UnitedHealth's Stock Price
M&A Strategy
UnitedHealth's continued acquisitions, such as Change Healthcare, enhance its data analytics and margins by increasing Optum Insight revenue by 30% in FY23 and improving the overall margin profile. This aggressive push consolidates the market, providing a robust path for growth.
Cyberattack Impact
The cyberattack led to significant operational disruptions and a $22 million ransom payment, impacting the company's financials with an estimated EPS reduction of $1.90 to $2.05 for FY24. While the financial impact is considered manageable, it does imply increased future CAPEX for cybersecurity.
Divestiture of Brazilian Business
The divestment reduces foreign exchange exposure, particularly given the Brazilian real's volatility, and aligns UnitedHealth with its strong U.S. market focus. It eliminates potential financial impacts, such as a hypothetical $590 million asset reduction from a 10% USD gain.
Healthcare Spending Growth
With U.S. healthcare spending projected to grow due to factors like aging populations and healthcare inflation, UnitedHealth stands to benefit from an estimated 5.1% CAGR in national health spending until 2030. This provides a solid foundation for projected organic growth and market share gains.
Review the original Analysis Commentary
UnitedHealth is demonstrating resilience and strategic foresight with its aggressive M&A strategy, making bold moves like acquiring Change Healthcare. This not only improves its data analytics game but also bolsters its margins significantly, predicting a promising revenue leap by 30% in the coming fiscal year. By aligning closely with the lucrative U.S healthcare market, UnitedHealth is well-poised to capitalize on the anticipated 5.1% growth in national health spending. Forecasts suggest a vibrant 8% revenue surge fueled by these strategic acquisitions and organic market advancement.
Even in the face of setbacks like the recent cyberattack, which had a measurable albeit manageable financial dent, UnitedHealth remains steadfast. The $22 million ransom and subsequent EPS reduction are cushioned by the company's robust growth foundation. Meanwhile, divesting from volatile markets like Brazil reflects UnitedHealth's sharpened focus on risk reduction and stability. The combined strength of these factors points to a bright trajectory for UnitedHealth’s stock, with an expected gradual upward trend in the short term and robust growth ahead throughout the coming month.
Comprehensive Analysis of UnitedHealth (UNH) Stock Market Performance
Our multifaceted analysis of UnitedHealth's stock market is grounded in the company's key news stories, insights from reputable analysts, as well as mathematical and technical evaluations. Taking into account assessments from each of these aspects in real-time helps us address the most crucial questions for investors in the most objective way possible:
- When should I take profit in UnitedHealth stock?
- When should I record a loss on UnitedHealth stock?
- What are analysts' forecasts for UnitedHealth stock?
- What is the future of UnitedHealth stock?
We forecast UnitedHealth stock performance using neural networks based on historical data on UnitedHealth stocks.
UnitedHealth Group, Inc. News influencing stock rates
As of now, Panda has combed through 9 news items directly related to UNH from the last 30 days. Out of these, 5 clearly showcase a bullish trend, while 2 display bearish tendencies, and 2 events are neutral.
The strength of the bullish trend outpaces the bearish sentiments by 2.73 times, indicating that the news backdrop is positively influencing the company’s stock price in the current outlook.
The news analyzed fell within the period from Aug 21, 2024, to Sep 10, 2024.
House Committee Warns CVS, Cigna, UnitedHealth CEOs to Correct Testimony or Face Legal Action
Top Stocks Hitting Record Highs: JPM, KO, LMT, UNH Soar
Hedge Funds' Top Picks: Amazon, Microsoft, Meta Lead the Pack
Hedge Funds Favor UnitedHealth: Key Insights from Goldman Sachs
Surgery Partners Surges 16% on UnitedHealth & TPG Buyout Interest
Oppenheimer Projects UnitedHealth Stock Could Hit $650
U.S. Uninsured Rate Surges to 8%, Highest Post-Pandemic Level
UnitedHealth Confirms Steady $2.10 Quarterly Dividend
Humana Stock Tumbles Amid Rising Medical Costs and Downgraded Earnings Outlook
UnitedHealth Group Soars for Eighth Straight Session, Beating Wall Street Expectations
UnitedHealth Group Inc. Is an American diversified healthcare company based in Minnetonka, Minnesota. UnitedHealth offers its products and services through two subsidiaries: UnitedHealthcare and Optum, together with its subsidiaries, the group serves about 70 million people in the United States. The company provides healthcare and insurance services for private and corporate clients. UnitedHealthcare and Optum provide health care benefits for people living in all 50 states in the United States and over 125 other countries.
In 1977, United HealthCare Corporation was formed to reorganize, but becomes the parent company of the earlier Charter Med Incorporated (1974). United HealthCare brings healthcare innovations such as pharmacy and drug pharmacies, doctor’s office software to control and manage costs, and more.
UnitedHealth daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Sep 15 | 604.65 | 599.21 | 609.00 | 1.63 |
| Sep 16 | 603.08 | 595.96 | 606.45 | 1.76 |
| Sep 17 | 598.49 | 595.74 | 602.80 | 1.19 |
| Sep 18 | 603.76 | 594.58 | 606.66 | 2.03 |
| Sep 19 | 613.18 | 605.70 | 618.70 | 2.15 |
| Sep 20 | 619.56 | 613.86 | 624.02 | 1.66 |
| Sep 21 | 624.39 | 615.02 | 633.13 | 2.94 |
| Sep 22 | 629.01 | 623.47 | 636.68 | 2.12 |
| Sep 23 | 630.77 | 623.83 | 635.19 | 1.82 |
| Sep 24 | 619.67 | 612.60 | 627.72 | 2.47 |
| Sep 25 | 611.86 | 608.68 | 615.78 | 1.17 |
| Sep 26 | 614.92 | 609.51 | 623.90 | 2.36 |
| Sep 27 | 616.64 | 612.70 | 621.58 | 1.45 |
| Sep 28 | 611.71 | 604.61 | 618.80 | 2.35 |
| Sep 29 | 620.03 | 613.33 | 625.86 | 2.04 |
| Sep 30 | 627.59 | 623.70 | 630.86 | 1.15 |
| Oct 01 | 626.84 | 621.32 | 633.61 | 1.98 |
| Oct 02 | 627.47 | 623.83 | 637.13 | 2.13 |
| Oct 03 | 624.83 | 617.08 | 630.83 | 2.23 |
| Oct 04 | 615.33 | 608.32 | 621.24 | 2.12 |
| Oct 05 | 617.79 | 613.72 | 623.48 | 1.59 |
| Oct 06 | 613.47 | 608.81 | 619.36 | 1.73 |
| Oct 07 | 611.02 | 603.32 | 616.76 | 2.23 |
| Oct 08 | 607.23 | 603.46 | 614.88 | 1.89 |
| Oct 09 | 611.24 | 604.88 | 618.69 | 2.28 |
| Oct 10 | 618.82 | 616.09 | 625.13 | 1.47 |
| Oct 11 | 622.78 | 619.66 | 631.87 | 1.97 |
| Oct 12 | 617.30 | 609.52 | 623.84 | 2.35 |
| Oct 13 | 613.71 | 610.40 | 618.87 | 1.39 |
| Oct 14 | 606.84 | 598.59 | 614.37 | 2.64 |
UnitedHealth Daily Price Targets
UnitedHealth Stock Forecast 09-15-2024.
Forecast target price for 09-15-2024: $604.65.
Positive dynamics for UnitedHealth shares will prevail with possible volatility of 1.608%.
Pessimistic target level: 599.21
Optimistic target level: 609.00
UnitedHealth Stock Forecast 09-16-2024.
Forecast target price for 09-16-2024: $603.08.
Negative dynamics for UnitedHealth shares will prevail with possible volatility of 1.730%.
Pessimistic target level: 595.96
Optimistic target level: 606.45
UnitedHealth Stock Forecast 09-17-2024.
Forecast target price for 09-17-2024: $598.49.
Negative dynamics for UnitedHealth shares will prevail with possible volatility of 1.172%.
Pessimistic target level: 595.74
Optimistic target level: 602.80
UnitedHealth Stock Forecast 09-18-2024.
Forecast target price for 09-18-2024: $603.76.
Positive dynamics for UnitedHealth shares will prevail with possible volatility of 1.990%.
Pessimistic target level: 594.58
Optimistic target level: 606.66
UnitedHealth Stock Forecast 09-19-2024.
Forecast target price for 09-19-2024: $613.18.
Positive dynamics for UnitedHealth shares will prevail with possible volatility of 2.101%.
Pessimistic target level: 605.70
Optimistic target level: 618.70
UnitedHealth Stock Forecast 09-20-2024.
Forecast target price for 09-20-2024: $619.56.
Positive dynamics for UnitedHealth shares will prevail with possible volatility of 1.628%.
Pessimistic target level: 613.86
Optimistic target level: 624.02
UNH (UNH) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 580.65 | 556.61 | 599.47 | 7.15 |
| Nov. | 610.62 | 584.97 | 619.04 | 5.50 |
| Dec. | 592.66 | 564.22 | 615.78 | 8.37 |
UnitedHealth forecast for this year
UnitedHealth Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $580.653. Pessimistic: $556.61. Optimistic: $599.47
UnitedHealth Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $610.615. Pessimistic: $584.97. Optimistic: $619.04
UnitedHealth Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $592.662. Pessimistic: $564.22. Optimistic: $615.78
UnitedHealth (UNH) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 576.66 | 559.71 | 586.69 | 4.60 |
| Feb | 565.59 | 539.46 | 587.99 | 8.25 |
| Mar | 560.16 | 545.04 | 569.91 | 4.36 |
| Apr | 583.35 | 570.40 | 594.90 | 4.12 |
| May | 594.90 | 575.63 | 613.46 | 6.17 |
| Jun | 588.48 | 578.24 | 608.60 | 4.99 |
| Jul | 561.29 | 552.20 | 568.02 | 2.79 |
| Aug | 546.81 | 535.98 | 561.24 | 4.50 |
| Sep | 551.73 | 542.46 | 559.34 | 3.02 |
| Oct | 558.68 | 542.25 | 568.07 | 4.54 |
| Nov | 569.07 | 552.68 | 583.07 | 5.21 |
| Dec | 559.85 | 548.77 | 570.27 | 3.77 |
UnitedHealth (UNH) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 592.77 | 571.79 | 609.49 | 6.19 |
| Feb | 627.63 | 600.51 | 637.42 | 5.79 |
| Mar | 618.97 | 600.77 | 639.02 | 5.99 |
| Apr | 617.85 | 594.13 | 632.31 | 6.04 |
| May | 593.01 | 567.40 | 606.18 | 6.40 |
| Jun | 564.19 | 555.73 | 572.99 | 3.01 |
| Jul | 571.30 | 559.99 | 578.84 | 3.26 |
| Aug | 543.54 | 522.01 | 559.19 | 6.65 |
| Sep | 569.95 | 559.01 | 596.97 | 6.36 |
| Oct | 603.12 | 581.77 | 612.53 | 5.02 |
| Nov | 587.93 | 560.41 | 599.92 | 6.59 |
| Dec | 570.64 | 554.55 | 597.69 | 7.22 |
UnitedHealth information and performance
UNITEDHEALTH GROUP CENTER, 9900 BREN ROAD EAST, MINNEAPOLIS, MN, US
Market capitalization of the UnitedHealth Group, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of UNH shares in the company outstanding by the market price of one share.
EBITDA of UnitedHealth is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
UnitedHealth (UNH) stock dividend
UnitedHealth last paid dividends on 09/16/2024. The next scheduled payment will be on 09/24/2024. The amount of dividends is $7.74 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Commentary
UnitedHealth Group stands at a pivotal moment where its high valuation seems out of touch with its current growth projections. Despite its solid business fundamentals, UNH appears overvalued, posing potential downside risks if the market's high expectations aren't met. Historically, the company's projections of 10-13% growth are rather underwhelming, and the current valuation exceeds historical norms, suggesting a potential correction could be forthcoming. This could impact stock performance negatively in the near future, despite the firm's strong operational history.
On average, the influence strength of the factors affecting UNH in the short term is significant but not overwhelmingly negative, leading to a reasonably neutral outlook for the stock. Analysts' revised EPS predictions highlight a more cautious stance, emphasizing market enthusiasm may be overestimated. Free cash flow metrics also imply operational adjustments could lie ahead, casting a shadow over further valuation expansion. Together, these factors paint a picture of tempered expectations both in the next 15 days and through the coming month, aligning with a prudent, neutral stance toward UNH’s immediate stock performance potential.